Global Enzyme-Linked Immunosorbent Assay (ELISA) Market 2023 by Company, Regions, Type and Application, Forecast to 2029

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samplesﾗserum, plasma, cell culture supernatants and cell lysatesﾗindicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
According to our (Global Info Research) latest study, the global Enzyme-Linked Immunosorbent Assay (ELISA) market size was valued at USD 184.2 million in 2022 and is forecast to a readjusted size of USD 233.5 million by 2029 with a CAGR of 3.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent. 
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
This report is a detailed and comprehensive analysis for global Enzyme-Linked Immunosorbent Assay (ELISA) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Enzyme-Linked Immunosorbent Assay (ELISA) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Enzyme-Linked Immunosorbent Assay (ELISA) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enzyme-Linked Immunosorbent Assay (ELISA)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enzyme-Linked Immunosorbent Assay (ELISA) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences and ZEUS Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Enzyme-Linked Immunosorbent Assay (ELISA) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Sandwich ELISA
    Indirect ELISA
    Competitive ELISA
    Others
Market segment by Application
    Immunology
    Inflammation
    Infectious Diseases
    Cancer
    Protein Quantitation
    Others
Market segment by players, this report covers
    R&D Systems
    Thermo Fisher Scientific
    Ortho Clinical Diagnostics
    BD Biosciences
    ZEUS Scientific
    Bio-Rad Laboratories
    ALPCO
    Enzo Life Sciences
    BioM�rieux
    EMD Millipore
    BioLegend
    LOEWE Biochemica
    Mercodia
    Cusabio
    Shanghai Kehua Bio-engineering
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Enzyme-Linked Immunosorbent Assay (ELISA) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Enzyme-Linked Immunosorbent Assay (ELISA), with revenue, gross margin and global market share of Enzyme-Linked Immunosorbent Assay (ELISA) from 2018 to 2023.
Chapter 3, the Enzyme-Linked Immunosorbent Assay (ELISA) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Enzyme-Linked Immunosorbent Assay (ELISA) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Enzyme-Linked Immunosorbent Assay (ELISA).
Chapter 13, to describe Enzyme-Linked Immunosorbent Assay (ELISA) research findings and conclusion.